Get the Stockscreener App
0.9538
1.45%
-0.014
After Hours:
1.00
0.0462
+4.84%
Cardiol Therapeutics Inc stock is traded at $0.9538, with a volume of 316.63K.
It is down -1.45% in the last 24 hours and down -9.16% over the past month.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.
See More
Previous Close:
$0.9678
Open:
$0.945
24h Volume:
316.63K
Relative Volume:
0.50
Market Cap:
$95.38M
Revenue:
-
Net Income/Loss:
$-21.65M
P/E Ratio:
-2.872
EPS:
-0.3321
Net Cash Flow:
$-15.84M
1W Performance:
-5.56%
1M Performance:
-9.16%
6M Performance:
-29.87%
1Y Performance:
-25.48%
1-Day Range:
$0.94
$0.9898
1-Week Range:
$0.94
$1.0187
52-Week Range:
$0.7709
$1.59
Cardiol Therapeutics Inc Stock (CRDL) Company Profile
Compare CRDL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRDL
Cardiol Therapeutics Inc
|
0.9538 | 96.78M | 0 | -21.65M | -15.84M | -0.3321 |
|
ZTS
Zoetis Inc
|
125.82 | 55.71B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.59 | 49.38B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.11 | 44.89B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.21 | 35.96B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
487.25 | 21.36B | 3.08B | 1.24B | 1.07B | 25.61 |
Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Initiated | H.C. Wainwright | Buy |
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Jun-26-24 | Initiated | ROTH MKM | Buy |
| Apr-22-24 | Initiated | H.C. Wainwright | Buy |
Cardiol Therapeutics Inc Stock (CRDL) Latest News
Movement Recap: Why Cardiol Therapeutics Inc stock could benefit from AI revolutionWeekly Risk Report & Risk Adjusted Swing Trade Ideas - moha.gov.vn
Trading (CRDL) With Integrated Risk Controls (CRDL:CA) - Stock Traders Daily
Cardiol TherapeuticsFinancial Details - Crunchbase
(CRDL) Stock Trading Blueprint (CRDL:CA) - Stock Traders Daily
HC Wainwright & Co. Reiterates Cardiol Therapeutics (CRDL) Buy Recommendation - MSN
(CRDL) Financial Trading Report (CRDL:CA) - Stock Traders Daily
Cardiol Therapeutics (TSE:CRDL) Stock Price Down 0.7% – Here’s Why - Defense World
Cardiol Therapeutics (TSE:CRDL) Stock Price Down 0.7%Here's Why - MarketBeat
Analysts Set Cardiol Therapeutics Inc. (NASDAQ:CRDL) Target Price at $8.00 - Defense World
CapEx per share of Cardiol Therapeutics Inc. – NASDAQ:CRDL - TradingView — Track All Markets
EBITDA per share of Cardiol Therapeutics Inc. – NASDAQ:CRDL - TradingView — Track All Markets
Why Cardiol Therapeutics Inc. stock attracts global investorsJuly 2025 News Drivers & Momentum Based Trading Ideas - Улправда
Is Cardiol Therapeutics Inc. stock near bottom after declineJuly 2025 Update & Growth Focused Entry Reports - Улправда
Why Cardiol Therapeutics Inc. stock could benefit from AI revolution2025 Macro Impact & Weekly Breakout Opportunity Watchlist - DonanımHaber
How Cardiol Therapeutics Inc. stock reacts to job market dataTrade Performance Summary & Short-Term Trading Alerts - DonanımHaber
Why Cardiol Therapeutics Inc. stock is favored by top institutions2025 Performance Recap & Capital Efficiency Focused Ideas - DonanımHaber
Is Cardiol Therapeutics Inc. (CT9) stock a momentum leaderMarket Sentiment Report & AI Enhanced Trading Alerts - Улправда
How institutional buying supports Cardiol Therapeutics Inc. stockWeekly Trade Report & Free Weekly Watchlist of Top Performers - Улправда
Moderna to Present at the 44th Annual J.P. Morgan Healthcare Conference - Investing News Network
Cardiol Therapeutics Inc. (NASDAQ:CRDL) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
(CRDL) Investment Analysis (CRDL:CA) - Stock Traders Daily
Cardiol Therapeutics Appoints Worldwide Clinical Trials as CRO for the Company's Phase II/III Outcomes Trial in High-Risk Patients Hospitalized with COVID-19 - TMX Newsfile
(CRDL) Proactive Strategies (CRDL:CA) - Stock Traders Daily
Moving Average Crossover Confirms Uptrend in Dhampur Sugar Mills LimitedStock Split Announcements & Identify Safe Investments - earlytimes.in
Investors in cash trouble should check out Cardiol Therapeutics Inc (CRDL) - setenews.com
Inflation Data: Will Cardiol Therapeutics Inc CT9 stock outperform small cap peersMarket Activity Report & Fast Entry Momentum Alerts - moha.gov.vn
(CRDL) Investment Analysis and Advice (CRDL:CA) - news.stocktradersdaily.com
Is Cardiol Therapeutics Inc. stock a defensive play in 2025July 2025 Analyst Calls & Safe Entry Point Alerts - Newser
Cardiol Therapeutics Reports Q3 2025 Financial Results Amidst Cash Decrease - MSN
(CRDL) Market Dynamics and Trading Signals (CRDL:CA) - news.stocktradersdaily.com
How buyback programs support Cardiol Therapeutics Inc. (CT9) stockAnalyst Upgrade & Proven Capital Preservation Tips - Newser
Why institutional investors increase stakes in Cardiol Therapeutics Inc. (CT9) stock2025 Retail Activity & Free Real-Time Market Sentiment Alerts - Newser
Should you sell your Cardiol Therapeutics stock? - Cantech Letter
Is Cardiol Therapeutics Inc. stock attractive for passive investorsMarket Performance Summary & Consistent Growth Stock Picks - Newser
Will Cardiol Therapeutics Inc. (CT9) stock announce special dividendWeekly Profit Recap & Daily Volume Surge Signals - Newser
Will Cardiol Therapeutics Inc. (CT9) stock issue positive guidanceJuly 2025 Action & Risk Controlled Swing Trade Alerts - Newser
What hedge fund moves indicate for Cardiol Therapeutics Inc. (CT9) stockMarket Movement Recap & Safe Entry Zone Identification - Newser
Will Cardiol Therapeutics Inc. stock deliver consistent dividendsJuly 2025 Catalysts & Risk Adjusted Buy/Sell Alerts - Newser
What RSI levels show for Cardiol Therapeutics Inc. (CT9) stock2025 Trading Recap & Consistent Growth Stock Picks - Newser
Taking the lead: Cardiol Therapeutics Inc (CRDL) - setenews.com
Cardiol Therapeutics (TSE:CRDL) Stock Price Down 14.6%Should You Sell? - MarketBeat
Cardiol Therapeutics (TSE:CRDL) Trading Down 14.6%Should You Sell? - MarketBeat
Will Cardiol Therapeutics Inc. (CT9) stock recover faster than industryJuly 2025 PreEarnings & Verified Momentum Stock Watchlist - Newser
Cardiol Therapeutics (TSE:CRDL) Shares Down 14.6%Here's What Happened - MarketBeat
Cardiol Therapeutics (TSE:CRDL) Shares Down 17.2%Here's What Happened - MarketBeat
Cardiol Therapeutics (TSE:CRDL) Shares Down 13.9%What's Next? - MarketBeat
Cardiol Therapeutics (TSE:CRDL) Trading Down 17.2%Here's What Happened - MarketBeat
Cardiol Therapeutics (NASDAQ:CRDL) Receives "Buy" Rating from HC Wainwright - MarketBeat
Cardiol Therapeutics (TSE:CRDL) Trading Down 7.9%Here's Why - MarketBeat
H.C. Wainwright reaffirms Buy rating on Cardiol Therapeutics stock at $9 target - Investing.com Nigeria
H.C. Wainwright reaffirms Buy rating on Cardiol Therapeutics stock at $9 target By Investing.com - Investing.com South Africa
Cardiol Therapeutics Inc Stock (CRDL) Financials Data
Revenue
Net Income
Cash Flow
EPS
8.30%
0.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):